EBV Related Non-Hodgkin's Lymphoma
Also known as: Epstein Barr Virus Associated Non Hodgkin's Lymphoma / Epstein-Barr Virus-Related Non-Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB00997 | Doxorubicin | 2 | Terminated | 1 |
| DB11714 | Durvalumab | 2 | Withdrawn | 1 |
| DB01005 | Hydroxyurea | 2 | Terminated | 1 |
| DB00480 | Lenalidomide | 2 | Withdrawn | 1 |
| DB00650 | Leucovorin | 2 | Terminated | 1 |
| DB00563 | Methotrexate | 2 | Terminated | 1 |
| DB15419 | Nanatinostat | 2 | Recruiting | 1 |
| DB00073 | Rituximab | 2 | Terminated | 1 |
| DB01610 | Valganciclovir | 2 | Recruiting | 1 |
| DB00495 | Zidovudine | 2 | Terminated | 1 |